Actavis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS, and what generic and branded alternatives to ACTAVIS drugs are available?
ACTAVIS has three hundred and twenty-five approved drugs.
There are twenty tentative approvals on ACTAVIS drugs.
Summary for Actavis
US Patents: | 0 |
Tradenames: | 229 |
Ingredients: | 218 |
NDAs: | 325 |
Patent Litigation for Actavis: | See patent lawsuits for Actavis |
PTAB Cases with Actavis as petitioner: | See PTAB cases with Actavis as petitioner |
Drugs and US Patents for Actavis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Elizabeth | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | bisoprolol fumarate; hydrochlorothiazide | TABLET;ORAL | 075672-003 | Sep 25, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Labs Fl Inc | FOSINOPRIL SODIUM | fosinopril sodium | TABLET;ORAL | 076620-002 | Oct 15, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Mid Atlantic | VALNAC | betamethasone valerate | CREAM;TOPICAL | 070050-001 | Oct 10, 1984 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Elizabeth | CLONAZEPAM | clonazepam | TABLET;ORAL | 074869-001 | Oct 31, 1996 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Actavis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.